Pubblicazioni

Risankizumab versus Secukinumab: a real-world efficacy and cost per responder comparison in patients with psoriasis in Italy

2025 - DERMATOLOGY PRACTICAL & CONCEPTUAL

Pirro, Federico; Caldarola, Giacomo; Bernardini, Nicoletta; Celeste, Maria Grazia; Dattola, Annunziata; De Luca, Eleonora; Galluzzo, Marco; Giordano, Domenico; Izzi, Chiara; Maretti, Giulia; Marcelli, Lorenzo; Ravasio, Roberto; Richetta, Antonio Giovanni; Skroza, Nevena; Talamonti, Marina; Zangrilli, Arianna; Bianchi, Luca; Pellacani, Giovanni; Persechino, Severino; Potenza, Concetta; Peris, Ketty; De Simone, Clara

Efficacy and safety of intra-class switching from Ixekizumab to Secukinumab in patients with plaque psoriasis. A multicenter retrospective study

2024 - JOURNAL OF PERSONALIZED MEDICINE

Bernardini, Nicoletta; Dattola, Annunziata; Rossi, Raimondo; Pagnanelli, Gianluca; Amerio, Paolo; Atzori, Laura; Mugheddu, Cristina; Lora, Viviana; Giordano, Domenico; Guacci, Lucia Finistauri; Persechino, Severino; Richetta, Antonio Giovanni; Skroza, Nevena; Potenza, Concetta

Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study

2023 - CLINICAL, COSMETIC AND INVESTIGATIONAL DERMATOLOGY

Talamonti, Marina; Russo, Filomena; Malara, Giovanna; Hansel, Katharina; Papini, Manuela; Cattaneo, Angelo; Parodi, Aurora; Chiricozzi, Andrea; Malagoli, Piergiorgio; Bardazzi, Federico; Brazzelli, Valeria; Dapavo, Paolo; Gisondi, Paolo; Zane, Cristina; Potenza, Concetta; Cantoresi, Franca; Fargnoli, Maria Concetta; Trevisini, Sara; Brianti, Pina; Pescitelli, Leonardo; Gigante, Giovanni; Bartezaghi, Marta; Caputo, Luisa; Aloisi, Elisabetta; Costanzo, Antonio

The role of interleukin-17 in juvenile idiopathic arthritis: from pathogenesis to treatment

2022 - MEDICINA

Paroli, Marino; Spadea, Luca; Caccavale, Rosalba; Spadea, Leopoldo; Paroli, Maria Pia; Nante, Nicola

Secukinumab Treatment in Patients with Spondyloarthritis and Concomitant Demyelinating Disease: Rationale of IL-17 Inhibition and Clinical Outcome.

2022 - ARCHIVES OF CLINICAL AND MEDICAL CASE REPORTS

Scrivo, Rossana; PICCHIANTI DIAMANTI, Andrea; Sole Chimenti, Maria; Molteni, Emanuele; Sciarra, Giorgio; Federico, Bari; Greco, MARIA ELISABETTA; Bergamini, Alberto; Lagana', Bruno; Conti, Fabrizio

A real-world economic analysis of biologic therapies for psoriatic arthritis in italy. results of the CHRONOS observational longitudinal study

2022 - BMC HEALTH SERVICES RESEARCH

Zagni, Emanuela; Frassi, Micol; Mariano, Giuseppa Pagano; Fusaro, Enrico; Lomater, Claudia; Del Medico, Patrizia; Iannone, Florenzo; Foti, Rosario; Limonta, Massimiliano; Marchesoni, Antonio; Raffeiner, Bernd; Viapiana, Ombretta; Grassi, Walter; Grembiale, Rosa Daniela; Guggino, Giuliana; Mazzone, Antonino; Tirri, Enrico; Perricone, Roberto; Sarzi Puttini, Pier Carlo; De Vita, Salvatore; Conti, Fabrizio; Zullo, Alessandro; Simoni, Lucia; Fiocchi, Martina; Orsenigo, Roberto; Colombo, Delia

Why targeted therapeutics have provided benefit in psoriasis: looking at IL-17 biology

2022 - EXPERT REVIEW OF CLINICAL PHARMACOLOGY

Lanna, Caterina; Lambiase, Sara; Gaeta Shumak, Ruslana; Borselli, Cristiana; Cosio, Terenzio; Dattola, Annunziata; Bianchi, Luca; Campione, Elena

Vitiligo with Progressive Repigmentation during Secukinumab Treatment in a Patient with Psoriatic Arthritis. A Case Report

2021 - CASE REPORTS IN DERMATOLOGY

Giordano, D.; Magri, F.; Persechino, F.; Lepore, A.; Verde, R.; Capalbo, A.; Persechino, S.

Secukinumab improves patient perception of anxiety and depression in patients with moderate to severe psoriasis. A post hoc analysis of the SUPREME study

2021 - ACTA DERMATO-VENEREOLOGICA

Talamonti, M; Malara, G; Natalini, Y; Bardazzi, F; Conti, A; Chiricozzi, A; Mugheddu, C; Gisondi, P; Piaserico, S; Pagnanelli, G; Amerio, P; Potenza, C; Cantoresi, F; Fargnoli, Mc; Balato, A; Loconsole, F; Offidani, A; Bonifati, C; Prignano, F; Bartezaghi, M; Rausa, A; Aloisi, E; Orsenigo, R; Costanzo, A; the SUPREME Study, Group. Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study.

Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature.

2020 - EXPERT OPINION ON BIOLOGICAL THERAPY

Caldarola, G; Pirro, F; Di Stefani, A; Talamonti, M; Galluzzo, M; D'Adamio, S; Magnano, M; Bernardini, N; Malagoli, P; Bardazzi, F; Potenza, C; Bianchi, L; Peris, K; De Simone, C.

A rare case of drug-induced erectile dysfunction with secukinumab solved after switch to ixekizumab in a psoriatic patient. a case report

2020 - CURRENT DRUG SAFETY

Dastoli, S; Iannone, Lf; Bennardo, L; Silvestri, M; Palleria, C; Nistico', S; Russo, E.; De Sarro, G

Secukinumab may be a valid treatment option in patients with CNS demyelination and concurrent ankylosing spondylitis: Report of two clinical cases

2019 - MULTIPLE SCLEROSIS AND RELATED DISORDERS

Cortese, Antonio; Lucchetti, Ramona; Altobelli, Alessio; Conte, Antonella; Primavera, Marco; Valesini, Guido; Millefiorini, Enrico; Scrivo, Rossana

Optimizing Secukinumab Treatment in Psoriasis with Concomitant Methotrexate Administration: Minireview and A Case Report

2019 - CASE REPORTS IN DERMATOLOGY

Kostaki, D.; Aquila, E.; Macaluso, L.; Mattozzi, C.; Richetta, A. G.

Successful therapy of plaque-type psoriasis with secukinumab in patients with multiple comorbidities treated with previous biologic therapies

2018 - THE JOURNAL OF DERMATOLOGICAL TREATMENT

Lasagni, C.; Bigi, L.; Conti, A.; Pellacani, G.